| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.31 | 6e-10 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.37 | 4e-09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.089 | 0.07 |